Enovis Return on Tangible Equity 2010-2024 | ENOV

Current and historical return on tangible equity values for Enovis (ENOV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Enovis Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.12B $-0.46B 40.61%
2024-06-30 $-0.09B $-0.45B 88.56%
2024-03-31 $-0.08B $-0.51B -96.47%
2023-12-31 $-0.03B $0.23B -10.75%
2023-09-30 $-0.08B $0.31B -22.21%
2023-06-30 $-0.14B $0.31B -40.61%
2023-03-31 $-0.05B $0.38B -13.73%
2022-12-31 $-0.01B $0.36B -7.94%
2022-09-30 $0.02B $0.33B 4.78%
2022-06-30 $0.12B $0.45B 46.54%
2022-03-31 $0.07B $-0.43B -151.11%
2021-12-31 $0.07B $1.57B -65.60%
2021-09-30 $0.11B $-0.59B -12.58%
2021-06-30 $0.09B $-0.73B -8.89%
2021-03-31 $0.06B $-0.69B -4.59%
2020-12-31 $0.04B $-1.39B -2.91%
2020-09-30 $-0.01B $-1.42B 0.55%
2020-06-30 $-0.01B $-1.47B 0.70%
2020-03-31 $-0.47B $-1.50B 28.06%
2019-12-31 $-0.53B $-1.43B 25.73%
2019-09-30 $-0.47B $-1.91B 34.29%
2019-06-30 $-0.44B $-1.88B 50.77%
2019-03-31 $0.06B $-2.98B -16.30%
2018-12-31 $0.14B $1.35B 33.96%
2018-09-30 $0.11B $0.01B 91.06%
2018-06-30 $0.12B $0.07B 96.06%
2018-03-31 $0.14B $0.21B 318.60%
2017-12-31 $0.15B $0.17B -173.56%
2017-09-30 $0.18B $0.05B -101.44%
2017-06-30 $0.16B $-0.26B -55.00%
2017-03-31 $0.15B $-0.31B -42.90%
2016-12-31 $0.13B $-0.17B -32.93%
2016-09-30 $0.14B $-0.40B -27.69%
2016-06-30 $0.13B $-0.47B -23.56%
2016-03-31 $0.14B $-0.52B -26.67%
2015-12-31 $0.17B $-0.56B -32.67%
2015-09-30 $0.20B $-0.58B -39.57%
2015-06-30 $0.26B $-0.42B -51.78%
2015-03-31 $0.40B $-0.50B -73.65%
2014-12-31 $0.37B $-0.56B -100.82%
2014-09-30 $0.33B $-0.52B -92.53%
2014-06-30 $0.30B $-0.58B -105.78%
2014-03-31 $0.16B $0.19B -76.17%
2013-12-31 $0.16B $-0.50B -36.94%
2013-09-30 $0.14B $-0.25B -28.57%
2013-06-30 $0.09B $-0.29B -16.94%
2013-03-31 $0.05B $-0.66B -7.78%
2012-12-31 $-0.08B $-0.72B 15.66%
2012-09-30 $-0.11B $-0.50B 31.34%
2012-06-30 $-0.11B $-0.48B 48.93%
2012-03-31 $-0.11B $-0.42B 105.97%
2011-12-31 $0.01B $-0.06B 166.67%
2011-09-30 $0.03B $0.03B 141.18%
2011-06-30 $0.03B $0.03B 160.00%
2011-03-31 $0.02B $0.01B 143.28%
2010-12-31 $0.02B $0.02B 93.15%
2010-09-30 $0.02B $0.02B 61.22%
2010-06-30 $0.02B $0.02B 65.93%
2010-03-31 $0.02B $0.02B 83.95%
2009-12-31 $0.02B $0.04B 168.42%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.529B $1.707B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00